Udenyca Injection, Solution
Product Images NDC 70114-101

21 FDA label images from Coherus Oncology, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Udenyca (NDC 70114-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Coherus Oncology, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Udenyca Before Use (Udenyca 01)

Image Of Udenyca Before Use (Udenyca 01)
A labeled diagram illustration of a prefilled syringe showing parts including the needle cap, needle, needle safety guard (unactivated), syringe body, label, inspection window, finger grips, plunger, and plunger head. This schematic aids in identifying components of the injection device.*
FDA Label Image

Image Of Udenyca After Use (Udenyca 02)

Image Of Udenyca After Use (Udenyca 02)
An instructional diagram labeled Figure 2 showing a partially disassembled syringe with a needle safety guard activated, indicating a safety feature to cover the needle after use.*
FDA Label Image

Image Of Storage (instructions for use)

Image Of Storage (instructions for use)
An illustration showing a box labeled UDENYCA (pegfilgrastim-cbqv) next to an open refrigerator, with an arrow pointing from the box toward the refrigerator interior shelves, depicting storage of the product in a refrigerator.*
FDA Label Image

Image Of Removal From Storage (instructions for use)

Image Of Removal From Storage (instructions for use)
An instructional diagram showing a hand holding a UDENYCA (pegfilgrastim-cbqv) injection solution cartridge, with an arrow indicating insertion into a device. The image also shows a close-up of the cartridge's expiration date location marked as 'EXP: 2019 JAN.'*
FDA Label Image

Image Of Opening Udenyca (instructions for use)

Image Of Opening Udenyca (instructions for use)
An instructional illustration showing hands holding and removing the outer packaging of a UDENYCA pegfilgrastim-cbqv injection, solution 6 mg/.6 mL, to reveal the prefilled syringe inside. The image focuses on proper handling of the product carton or tray.*
FDA Label Image

Image Of Time To Reach Room Temp (instructions for use)

Image Of Time To Reach Room Temp (instructions for use)
An instructional diagram showing a stopwatch set at 30 minutes with an arrow curving clockwise, indicating a 30-minute time interval.*
FDA Label Image

Image Of Gathering Supplies (instructions for use)

Image Of Gathering Supplies (instructions for use)
An instructional illustration showing four items: a sharps disposal container with a label reading 'Sharps Container,' an alcohol wipe packet, a cotton ball, and an adhesive bandage. These are likely depicted as supplies for injection site care or disposal.*
FDA Label Image

Image Of Proper Hand Washing (instructions for use)

Image Of Proper Hand Washing (instructions for use)
An instructional illustration showing handwashing technique with soap and running water. One hand is rubbing the back of the other hand to demonstrate thorough cleaning, typical in hygiene or injection preparation instructions.*
FDA Label Image

Image Of Removal Of Udenyca From Tray (instructions of use)

Image Of Removal Of Udenyca From Tray (instructions of use)
Illustration showing the UDENYCA (pegfilgrastim-cbqv) prefilled syringe within its packaging and a hand holding the syringe, possibly demonstrating removal or preparation steps. The syringe is designed for subcutaneous injection, as indicated by the product data.*
FDA Label Image

Image Of Visual Inspection (instructions for use)

Image Of Visual Inspection (instructions for use)
An instructional illustration showing a hand holding an injection pen labeled UDENYCA. The diagram points out an labeled 'Inspection Window' on the pen, highlighting where to visually check the medication inside the device prior to injection.*
FDA Label Image

Image Of Injection Site Selection (instructions for use)

Image Of Injection Site Selection (instructions for use)
An instructional diagram showing recommended subcutaneous injection sites for UDENYCA (pegfilgrastim-cbqv). Front and back human body outlines highlight injection areas: abdomen, thigh, upper outer buttock, and back of upper arm.*
FDA Label Image

Image Of Cleaning Injection Site (instructions for use)

Image Of Cleaning Injection Site (instructions for use)
An instructional illustration showing a hand holding a piece of cloth or wipe, cleaning a circular area on a surface. This figure appears to demonstrate a preparation step, likely related to sanitation or sterilization before an injection procedure.*
FDA Label Image

Image Of Removal Of Needle Cap (instructions for use)

Image Of Removal Of Needle Cap (instructions for use)
An instructional illustration showing the removal of a syringe plunger from a syringe barrel. The first frame depicts hands holding the syringe by the barrel with the plunger partially depressed. The second frame shows the plunger being pulled straight out from the syringe barrel, indicated by an upward arrow.*
FDA Label Image

Image Of Position Of Fingers (instructions for use)

Image Of Position Of Fingers (instructions for use)
An instructional illustration showing a hand holding a prefilled syringe labeled UDENYCA (pegfilgrastim-cbqv) 6 mg/0.6 mL for subcutaneous injection. The image demonstrates proper grip and syringe positioning for administration.*
FDA Label Image

Image Of Pinching Skin Of Injection Site (instructions for use)

Image Of Pinching Skin Of Injection Site (instructions for use)
An instructional illustration labeled Figure 14 showing a hand pinching the skin on an arm, likely demonstrating the proper technique for preparing or administering a subcutaneous injection.*
FDA Label Image

Image Of Proper Needle Insertion (instructions for use)

Image Of Proper Needle Insertion (instructions for use)
An instructional illustration showing the correct technique for subcutaneous injection. It depicts a hand holding a syringe at a 45-degree angle to the skin, with another hand stabilizing the injection site. The image includes angle indicators showing 90 degrees and 45 degrees to guide proper injection angle.*
FDA Label Image

Image Of Injection Finger Positioning (instructions for use)

Image Of Injection Finger Positioning (instructions for use)
An instructional illustration showing hands preparing a subcutaneous injection using a syringe with an attached needle, demonstrating the technique for UDENYCA (pegfilgrastim-cbqv) injection, solution, 6 mg/0.6 mL.*
FDA Label Image

Image Of Plunger Push (instructions for use)

Image Of Plunger Push (instructions for use)
An instructional illustration showing how to remove or prepare a subcutaneous injection using a prefilled syringe. The figure focuses on the hand holding the syringe, with a close-up inset highlighting the syringe tip and cap, indicating the direction to pull or twist to remove the protective cap before administration.*
FDA Label Image

Image Of Needle Retraction (instructions for use)

Image Of Needle Retraction (instructions for use)
Illustration showing two steps of preparing an injection from a prefilled syringe, including removing a cap and pulling back on the plunger, likely for UDENYCA pegfilgrastim-cbqv 6 mg/.6 mL subcutaneous injection.*
FDA Label Image

Image Of Disposal (instructions for use)

Image Of Disposal (instructions for use)
An instructional illustration showing a hand safely disposing of a used prefilled injection syringe labeled UDENYCA pegfilgrastim-cbqv into a labeled sharps container, indicating proper disposal of the subcutaneous injection device.*
FDA Label Image

Image Of Carton Label (principal panel)

Image Of Carton Label (principal panel)
UDENYCA 6 mg/0.6 mL injection, solution for subcutaneous use, containing pegfilgrastim-cbqv. The label highlights a 6 mg in 0.6 mL single-dose prefilled syringe of sterile solution with no preservative. It is a pegylated recombinant methionyl human granulocyte colony-stimulating factor derived from E. coli. The labeler is Coherus Oncology, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.